Group leader at GIMM (Lisbon, Portugal); professor at the University of Lisbon (Portugal)
Gulbenkian Institute for Molecular Medicine
Lisbon, Portugal
2 profile visits
Our lab is dedicated to study the molecular interactions between clinically relevant compounds and biological systems, resorting to both cellular and animal models. Our primary focus is on peptides.
Our vision is to create a globally leading scientific research institute that will generate multi- and cross-disciplinary knowledge to answer fundamental questions of biology and human health in a fast-evolving environment. All while developing solutions to improve health outcomes and promote local and global health equity.
Our lab is dedicated to study the molecular interactions between clinically relevant compounds and biological systems, resorting to both cellular and animal models. By understanding the physical principles that drive these interactions, we aim to design new therapeutic strategies or enhance the efficacy of existing ones. Our primary focus is the development of drug therapies and drug delivery systems, with an emphasis on peptides drugs. Our multidisciplinary approach has been applied to pandemic preparedness for infectious diseases, triple-negative breast cancer and its brain metastases, pediatric brain cancer, neurodegenerative disorders, and ocular diseases.